Revance Therapeutics disclosed salaries
Last updated
H-1B/LCA filings put the median disclosed base wage at Revance Therapeutics around US$149,972 a year. Here's the disclosed pay range and how it breaks down by role.
Disclosed base wage
The median disclosed base wage is US$149,972 a year, with most filings between US$126,733 and US$168,375.
| 25th percentile | US$126,733 |
|---|---|
| Median (50th percentile) | US$149,972 |
| 75th percentile | US$168,375 |
Disclosed base wage, from 39 H-1B/LCA filings, U.S. DOL OFLC, as of 2025.
This is the base wage employers attest on H-1B/LCA filings to meet the prevailing wage — it leaves out equity and bonus and reflects visa-sponsored hires, so it runs lower than total compensation. Read it alongside the advertised salary on each role page.
| Period | 25th percentile | Median | 75th percentile |
|---|---|---|---|
| 2021 | US$129,466 | US$149,726 | US$152,863 |
| 2022 | US$154,979 | US$175,489 | US$183,245 |
| 2024 | US$122,515 | US$141,750 | US$162,500 |
| 2025 | US$145,000 | US$166,750 | US$180,000 |
Disclosed wage data from the U.S. Department of Labor, OFLC.
Prep for these roles
CodePrep turns a job description into an adaptive quiz from a bank of tagged questions, scores your answers, and resurfaces the topics you miss.